223 related articles for article (PubMed ID: 2567703)
21. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
Schubert J; Heiken H; Jacobs R; Delany P; Witte T; Schmidt RE
Nat Immun Cell Growth Regul; 1990; 9(2):103-11. PubMed ID: 2141105
[TBL] [Abstract][Full Text] [Related]
22. Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16).
Anasetti C; Martin PJ; June CH; Hellstrom KE; Ledbetter JA; Rabinovitch PS; Morishita Y; Hellstrom I; Hansen JA
J Immunol; 1987 Sep; 139(6):1772-9. PubMed ID: 2957436
[TBL] [Abstract][Full Text] [Related]
23. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
[TBL] [Abstract][Full Text] [Related]
24. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
[TBL] [Abstract][Full Text] [Related]
25. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells.
Garni-Wagner BA; Purohit A; Mathew PA; Bennett M; Kumar V
J Immunol; 1993 Jul; 151(1):60-70. PubMed ID: 8326140
[TBL] [Abstract][Full Text] [Related]
26. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
27. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
28. Immunomodulatory properties of soluble recombinant human CD58 (LFA-3) molecules.
Albert-Wolf M; Meuer SC; Wallich R
Dev Biol Stand; 1992; 77():87-92. PubMed ID: 1385237
[TBL] [Abstract][Full Text] [Related]
29. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
30. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
Dadmarz R; Bockstoce DC; Golub SH
Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
[TBL] [Abstract][Full Text] [Related]
32. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity.
Chong AS; Boussy IA; Jiang XL; Lamas M; Graf LH
Cell Immunol; 1994 Aug; 157(1):92-105. PubMed ID: 7518755
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
34. K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
Shanahan F; Brogan MD; Newman W; Targan SR
J Immunol; 1986 Jul; 137(2):723-6. PubMed ID: 3487579
[TBL] [Abstract][Full Text] [Related]
35. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.
Lanier LL; Ruitenberg JJ; Phillips JH
J Immunol; 1988 Nov; 141(10):3478-85. PubMed ID: 2903193
[TBL] [Abstract][Full Text] [Related]
36. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
37. Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation.
Faure F; Jitsukawa S; Meuer S; Bohuon C; Triebel F; Hercend T
J Immunol; 1988 Apr; 140(7):2128-32. PubMed ID: 2895149
[TBL] [Abstract][Full Text] [Related]
38. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
Gray JD; Hirokawa M; Ohtsuka K; Horwitz DA
J Immunol; 1998 Mar; 160(5):2248-54. PubMed ID: 9498764
[TBL] [Abstract][Full Text] [Related]
39. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
40. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]